Literature DB >> 33089381

ALDOA protects cardiomyocytes against H/R-induced apoptosis and oxidative stress by regulating the VEGF/Notch 1/Jagged 1 pathway.

Gaiying Luo1, Rui Wang2, Hui Zhou2, Xiaoling Liu3.   

Abstract

Myocardial infarction (MI) is a myocardial necrosis disease caused by continuous ischemia and hypoxia. Abnormal expression of aldolase A (ALDOA) has been reported in cardiac hypertrophy, heart failure and other cardio-cerebrovascular diseases. The present study aims to explore the effects of ALDOA on hypoxia/reperfusion (H/R)-induced oxidative stress, and investigate the underlying mechanisms. ALDOA was expressed at a low level in blood samples from MI patients and H/R-induced H9C2 cardiomyocytes. Overexpression of ALDOA suppressed H/R-induced oxidative stress and apoptosis. Using co-immunoprecipitation and protein blots, we demonstrated that ALDOA modulates the Notch 1-Jagged 1 signalling pathway by upregulating VEGF. Taken together, our data reveal that ALDOA protects cardiomyocytes from H/R-induced oxidative stress through the VEGF/Notch 1/Jagged 1 axis, and should be investigated as a therapeutic target for the treatment of MI in future.

Entities:  

Keywords:  Aldolase A; Apoptosis; Cardiomyocytes; Oxidative stress

Mesh:

Substances:

Year:  2020        PMID: 33089381     DOI: 10.1007/s11010-020-03943-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

Review 1.  Acute Myocardial Infarction.

Authors:  Jeffrey L Anderson; David A Morrow
Journal:  N Engl J Med       Date:  2017-05-25       Impact factor: 91.245

2.  Ginsenoside Rg1 protects H9c2 cells against nutritional stress-induced injury via aldolase /AMPK/PINK1 signalling.

Authors:  ZhiMeng Xu; ChengBin Li; QingLing Liu; Hua Yang; Ping Li
Journal:  J Cell Biochem       Date:  2019-06-18       Impact factor: 4.429

3.  Comparative Proteome Profiling during Cardiac Hypertrophy and Myocardial Infarction Reveals Altered Glucose Oxidation by Differential Activation of Pyruvate Dehydrogenase E1 Component Subunit β.

Authors:  Arkadeep Mitra; Trayambak Basak; Shadab Ahmad; Kaberi Datta; Ritwik Datta; Shantanu Sengupta; Sagartirtha Sarkar
Journal:  J Mol Biol       Date:  2014-11-08       Impact factor: 5.469

4.  Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.

Authors:  Bertil Lindahl; Tomasz Baron; David Erlinge; Nermin Hadziosmanovic; Anna Nordenskjöld; Anton Gard; Tomas Jernberg
Journal:  Circulation       Date:  2017-02-08       Impact factor: 29.690

5.  Temporal trends in acute myocardial infarction presentation and association with use of cardioprotective drugs: a nationwide registry-based study.

Authors:  Laerke Smedegaard; Mette Gitz Charlot; Gunnar Hilmar Gislason; Peter Riis Hansen
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2018-04-01

6.  Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.

Authors:  Yapeng Li; Dianhong Zhang; Lingyao Kong; Huiting Shi; Xinyu Tian; Lu Gao; Yuzhou Liu; Leiming Wu; Binbin Du; Zhen Huang; Cui Liang; Zheng Wang; Rui Yao; Yanzhou Zhang
Journal:  Exp Cell Res       Date:  2018-06-11       Impact factor: 3.905

Review 7.  Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis.

Authors:  Li-jun Hu; Yun-qing Chen; Song-bai Deng; Jian-lin Du; Qiang She
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

8.  Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Caroline J Coats; Wendy E Heywood; Alex Virasami; Nadia Ashrafi; Petros Syrris; Cris Dos Remedios; Thomas A Treibel; James C Moon; Luis R Lopes; Christopher G A McGregor; Michael Ashworth; Neil J Sebire; William J McKenna; Kevin Mills; Perry M Elliott
Journal:  Circ Genom Precis Med       Date:  2018-12

9.  miR-7a/b attenuates post-myocardial infarction remodeling and protects H9c2 cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and PARP-1.

Authors:  Rui Li; Hai-Hua Geng; Jie Xiao; Xiao-Teng Qin; Fu Wang; Jun-Hui Xing; Yan-Fei Xia; Yang Mao; Jing-Wen Liang; Xiao-Ping Ji
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

10.  G6PC3, ALDOA and CS induction accompanies mir-122 down-regulation in the mechanical asphyxia and can serve as hypoxia biomarkers.

Authors:  Yan Zeng; Yehui Lv; Li Tao; Jianlong Ma; Heng Zhang; Hongmei Xu; Bi Xiao; Qun Shi; Kaijun Ma; Long Chen
Journal:  Oncotarget       Date:  2016-10-26
View more
  2 in total

Review 1.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

2.  Nogo-B promotes angiogenesis and improves cardiac repair after myocardial infarction via activating Notch1 signaling.

Authors:  Yanjun Zheng; Jingrong Lin; Dingsheng Liu; Guoqing Wan; Xuefeng Gu; Jian Ma
Journal:  Cell Death Dis       Date:  2022-04-05       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.